Prognostic factors in young women with epithelial ovarian cancer: the Young Ovarian Cancer-Care (YOC-Care) study.
Leticia AzconaMarta HerasOctavio ArencibiaLucas MinigLola MartiAndreea BaciuJuan CespedesIsabel NiguezBlanca Gil-IbañezBerta Díaz-FeijooLidia Maria MeleroJosefa Marcos SanmartinJose Garcia-VillayzanBenjamina GomezManel MontesinosSofía Herrero GámizJuan Gilabert-EstellesMaria F ChereguiniMikel GorostidiIgnacio Zapardiel Gutiérreznull nullPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
The partial and progression radiology-based response after chemotherapy, neoadjuvant chemotherapy, and advanced FIGO stage are independent prognostic factors associated with worse oncological outcomes in women aged <45 years with epithelial ovarian cancer.
Keyphrases
- neoadjuvant chemotherapy
- prognostic factors
- locally advanced
- healthcare
- rectal cancer
- palliative care
- quality improvement
- sentinel lymph node
- lymph node
- polycystic ovary syndrome
- squamous cell carcinoma
- affordable care act
- artificial intelligence
- radiation therapy
- type diabetes
- adipose tissue
- metabolic syndrome
- minimally invasive
- weight loss
- breast cancer risk
- glycemic control